Core Laboratories terminates $60M ATM program; no shares sold under agreement

Core Laboratories Inc. /DE/

Terminated Equity Distribution Agreement dated June 9, 2022 with Wells Fargo and BofA.
Program authorized up to $60M in 'at the market' common stock offerings; zero shares were ever sold.
Termination effective July 17, 2023; no future sales under this program.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Core Laboratories Inc. /DE/ terminated Equity Distribution Agreement with Wells Fargo Securities LLC and BofA Securities Inc. valued at $60,000,000 (effective 2023-07-17).

Action: termination
Agreement: atm program
Counterparty: Wells Fargo Securities LLC and BofA Securities Inc.
Value: $60,000,000
Effective: 2023-07-17

Exact text from the filing

On July 17, 2023, Core Laboratories Inc. (the “Company”), terminated the Equity Distribution Agreement dated June 9, 2022 (the “Distribution Agreement”).

View on SEC.gov

Browse all material agreements →

Core Laboratories Inc. /DE/ filing history →

Source: SEC EDGAR

accession 0000950170-23-033405

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.